Supplements maker DSM has reported a net sales growth of 6 percent to EURO1.92billion in 2015 as opposed to EURO1.81billion in 2014. This was bolstered by strong organic growth in the nutrition division.

Nutrition posted 7 percent organic growth (3 percent EBITDA). The company stated that despite lower prices of Vitamin E having a negative impact on the fourth quarter – reducing core earnings by 25 per cent EURO25 million – it predicted that prices would stabilize. Likewise it was on course to hit cost savings and productivity targets.

Feike Sijbesma, CEO/Chairman of the DSM Managing Board, said, “We expect to make further progress with our growth initiatives in 2016 both in Nutrition and Performance Materials although the macro-economic context remains challenging. These will be underpinned by our group-wide cost and productivity improvement programs as well as our disciplined focus on capital allocation and working capital. We are on track with these initiatives which will help drive improved profitability and return on capital that we target with our Strategy 2018.”